Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis. Dubey D, Cano CA, Stüve O Curr Opin Neurol. 2016 Mar 31. PMID: 27035896. Abstract CommentRecommendBookmarkWatch